SCHEMBL20879390

SCHEMBL20879390

CN(C)CCc1nc2ccccc2n1Cc1ccc(C(=O)NN=O)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 5/20 0.81
▸ HDAC6 Q9UBN7 5/20 0.81
▸ KCNH2 Q12809 1/20 0.58
▸ AGTR1 P30556 3/20 0.57
▸ AGTR2 P50052 3/20 0.57
▸ MAPT P10636 3/20 0.55
▸ PPARG P37231 1/20 0.54
▸ DRD2 P14416 2/20 0.54
▸ TBXA2R P21731 2/20 0.54
▸ KDM4E B2RXH2 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ TP53 P04637 1/20 0.49
▸ HDAC3 O15379 1/20 0.49
▸ HDAC4 P56524 1/20 0.49
▸ HDAC7 Q8WUI4 1/20 0.49
▸ HDAC2 Q92769 1/20 0.49
▸ HDAC10 Q969S8 1/20 0.49
▸ HDAC11 Q96DB2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12850061 0.89 HDAC1 (1.00) HDAC1HDAC6KCNH2AGTR1AGTR2
SCHEMBL15705709 0.89 HDAC1 (0.84) HDAC1HDAC6KCNH2AGTR1AGTR2
SCHEMBL12472634 0.85 HDAC1 (0.77) HDAC1HDAC6KCNH2AGTR1AGTR2
SCHEMBL9518750 0.81 HDAC1 (0.69) HDAC1HDAC6AGTR1AGTR2MAPT
SCHEMBL9518397 0.74 RAB9A (0.67) HDAC1HDAC6KCNH2AGTR1AGTR2
SCHEMBL9518580 0.74 MEN1 (0.61) HDAC1HDAC6AGTR1AGTR2MAPT
SCHEMBL15643267 0.73 KCNH2 (1.00) HDAC1HDAC6KCNH2MAPTDRD2
SCHEMBL9192299 0.73 AGTR1 (1.00) AGTR1AGTR2PPARGPOLB
SCHEMBL9201172 0.73 DRD2 (0.78) HDAC1HDAC6AGTR1AGTR2MAPT
SCHEMBL12850472 0.72 HDAC1 (1.00) HDAC1HDAC6KCNH2AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2670733-B1 N-HYDROXYBENZAMIDE DERIVATIVES AS HDAC INHIBITORS AND THERAPEUTIC METHODS USING THE SAME UNIV ILLINOIS (US) 2019-04-10 — — EP disclosed
Send feedback